IDSA News - June 2010  (Plain Text Version)

Return to Graphical Version

 

In this issue:
Patient Care and Science
•  ACIP Adjusts Seasonal Influenza Vaccination Recommendation for Children
•  Influenza and Intra-Abdominal Infections Guidelines Available as Pocketcards
•  Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
•  Physicians Narrowly Dodge 21 Percent Cuts in Medicare Payments
•  Medicare Internet Enrollment Deadline is July 6
•  GAO Report Calls for Study of Medicare Coverage of Home Infusion Therapy
•  Another Delay on FTC’s ‘Red Flag’ Rule on Identity Theft
Global ID
•  Preparing for the Future of Global HIV/AIDS Funding
Policy and Advocacy
•  IDSA Urges Action on Antibiotic Development at Congressional Hearing
•  AMA Endorses 10 x ’20 Initiative
Your Colleagues
•  Members on the Move
•  Welcome, New Members!
Education & Resources
•  Revised CPT Coding Resources Available
Top Stories
•  IDSA Annual Meeting Update
•  IDSA, FDA, and NIAID to Hold Antibacterial Resistance Research Workshop, July 26-27
•  Physicians Forced to Make Cutbacks as Medicare Eliminates Payment for Consultation Codes
•  IDSA Journal Club

 

ACIP Adjusts Seasonal Influenza Vaccination Recommendation for Children

The federal Advisory Committee on Immunization Practices (ACIP) last week recommended that children 6 months to 9 years of age who did not receive at least one dose of the 2009 H1N1 influenza vaccine last season should receive two doses of the upcoming seasonal vaccine. The committee also advised that children in this age group receive two doses if they received only the H1N1 vaccine previously.

The recommendation came in response to data presented at the ACIP meeting, June 23-24, regarding the immunogenicity of the H1N1 vaccine among different age groups. Reports presented to the committee continue to support the safety of the vaccine, according to IDSA’s ACIP liaison, Samuel Katz, MD, FIDSA. Several large studies of the H1N1 vaccine and of the meningococcal conjugate vaccine have revealed no Guillain-Barré Syndrome (GBS) in the 42 days following vaccination. Other updates suggested that supply of the 2010-2011 seasonal influenza vaccine, expected to be available in early autumn, would be more than adequate, Dr. Katz said.

Committee members also received an update on pertussis, which remains the most frequent vaccine-preventable infection, highlighted by a current outbreak in California involving five infant deaths. Vaccination of adolescents and adults—including postpartum mothers to prevent transmission to their newly born infants—must be enhanced, and more research is needed on administering the vaccine to pregnant women.